CE Mark Extended For Disc Dynamics' DASCOR(R) Disc Arthroplasty System
Main Category: Back PainAlso Included In: Regulatory Affairs / Drug Approvals
Article Date: 05 Jun 2009 - 6:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Health Professional: | ![]() |
5 (2 votes) |
| Article Opinions: | 0 posts |
Disc Dynamics, Inc., a leading developer of minimally invasive treatment options for low back pain caused by degenerative disc disease (DDD), announced that the CE Mark received in the European Union for its DASCOR® Disc Arthroplasty System has been expanded to incorporate a posterior-lateral surgical approach, as well as an endoscopic approach.
"DASCOR is the only motion preservation technology that can be delivered through multiple surgical approaches," said Steven Healy, president and CEO of Disc Dynamics. "Surgeons can now match the preferred surgical technique with the patient's anatomy."
The device consists of a two-part curable polyurethane and an expandable polyurethane balloon that is inserted into the disc nucleus space after the desiccated nucleus has been removed. The balloon is then injected with a flowable polymer, which creates a complete, patient-specific implant that conforms to the shape and size of the disc space.
In the U.S., Disc Dynamics is currently completing its IDE feasibility clinical study.
Source
Disc Dynamics
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |




